Bionumerik pharmaceuticals acquired
WebMar 18, 2008 · SAN ANTONIO and TOKYO, March 18 /PRNewswire/ -- BioNumerik Pharmaceuticals, Inc. ("BioNumerik") and ASKA Pharmaceutical Co., Ltd. ("ASKA") …
Bionumerik pharmaceuticals acquired
Did you know?
WebBioNumerik Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drugs that help in the treatment … WebJan 21, 2010 · BioNumerik Pharmaceuticals, Inc., based in San Antonio, Texas, is focused on the discovery, development and commercialization of novel drugs for the treatment of cancer and cancer supportive care ...
WebNov 18, 2024 · 31% of BioNumerik Pharmaceuticals employees are Asian. 18% of BioNumerik Pharmaceuticals employees are Hispanic or Latino. The average … WebThe estimated total pay for a BioNumerik Pharmaceuticals is $55,502 per year in the United States area, with an average salary of $51,532 per year. These numbers represent the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. The estimated additional pay is ...
WebBioNumerik Pharmaceuticals. In January 2024, the Company entered into an Assignment Agreement (the “Assignment Agreement”) with BioNumerik Pharmaceuticals, Inc. (“BioNumerik”), pursuant to which the Company acquired rights to domestic and international patents, trademarks and related technology and data relating to LP-300 … WebBioNumerik Pharmaceuticals focuses on the discovery, development, and commercialization of novel drugs for the treatment of cancer and cancer-supportive care. It provides drugs by merging medicine, quantum and statistical mechanics, pharmaceutical development, and supercomputing. The company was founded in 1992 and is based in …
WebFunding. BioNumerik Pharmaceuticals has raised a total of $63.3M in funding over 3 rounds. Their latest funding was raised on Nov 8, 2012 from a Venture - Series Unknown round. BioNumerik Pharmaceuticals is funded by Takeda. BioNumerik Pharmaceuticals has a post-money valuation in the range of $10M to $50M as of Dec 31, 2012, according …
WebMar 2, 2001 · The following is an excerpt from a S-1 SEC Filing, filed by BIONUMERIK PHARMACEUTICALS INC on 3/2/2001. Next Section: Previous Section ... was received by the receiving party from a third party who did not acquire it, directly or indirectly, from the disclosing party under any obligation of confidentiality and which the third party is free to ... grace dean university of buffalo gogglesWebFunding. BioNumerik Pharmaceuticals has raised a total of $63.3M in funding over 3 rounds. Their latest funding was raised on Nov 8, 2012 from a Venture - Series Unknown … grace dearborn chemical companyWebBionumerik Pharmaceuticals designs and develops small molecule drugs for the treatment of cancer and prevention of side effects associated with existing cancer therapies. chilled mango soupWebBNP1350 (Karenitecin, BioNumerik Pharmaceuticals) non–small cell lung cancer/ovarian cancer phase 2/phase 3 bortezomib (Velcade, Millennium) adenocarcinoma, diff use large B-cell lymphoma, T-cell prolymphocytic leukemia/mantle cell lymphoma, non-Hodgkin’s B … grace deforest weddingWebJun 14, 2012 · SAN ANTONIO, June 14, 2012 /PRNewswire/ -- BioNumerik Pharmaceuticals, Inc. ("BioNumerik") today announced the appointment of Mr. Steve Carchedi to BioNumerik's Board of Directors. chilled marbled chocolate cheesecakeWebBioNumerik Pharmaceuticals uses 11 technology products and services including HTML5, jQuery, and Google Analytics, according to G2 Stack. BioNumerik Pharmaceuticals is actively using 4 technologies for its website, according to BuiltWith. These include GoDaddy DNS, Person Schema, and Gravatar Profiles. grace dead tomorrow castWebJun 14, 2012 · SAN ANTONIO, June 14, 2012 /PRNewswire/ -- BioNumerik Pharmaceuticals, Inc. ("BioNumerik") today announced the appointment of Mr. Steve … chilled matcha